2018 Nobel Prize in Medicine Awarded to Cancer Immunotherapy Research
James P. Allison and Tasuku Honjo were recognized for a discovery that the body’s immune system can be used to attack cancer cells.
Patrick Nef, CEO at TransCure reacts to Jim Allison and Tasuku Honjo’s awards for their research on immunotherapy.
It’s a very good news for the scientific world and for the patients! We are proud to be part of this revolution. Since the first results published by James P. Allison and Tasuku Honjo, many of our customers have been involved in this immuno-oncology field. Indeed, our fully functional human immune system hu-mouse model is the preferred in vivo model for testing combination strategyPartick Nef